ADELPHI RETATRUTIDE 2MG

10 DOSES

10ML VIAL 

AUTHORISED DEALER 

https://adelphi-info.com

Adelphi Laboratories Retatrutide 2mg/ml – 10ml Vial

Retatrutide is a next-generation investigational peptide developed by Adelphi Laboratories, formulated at a concentration of 2mg/ml in a 10ml sterile, multi-dose vial. It is a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—designed to support advanced metabolic and obesity-related research.

Manufactured under strict quality control protocols, Retatrutide is intended for laboratory research use only. Each vial ensures high purity and consistency for preclinical studies involving glucose regulation, appetite modulation, and weight management mechanisms.